MedPath

SHORT TERM PROSPECTIVE STUDY OF UNCLASSIFIED TERMINAL ILEAL ULCER

Not Applicable
Conditions
Health Condition 1: K633- Ulcer of intestine
Registration Number
CTRI/2019/09/021399
Lead Sponsor
ANSHUMAN SINGH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Individuals referred for colonoscopy to the endoscopy unit of IPGME&R & SDLD for evaluation of gastrointestinal symptoms like diarrhoea, pain abdomen, fever, weight loss, occult gastrointestinal bleeding between 1st May 2019 to 31st January 2020, an attempt will be made to intubate the terminal ileum in all patients. Those with stable terminal ileal intubation will be evaluated for endoscopic mucosal ulcers.

2) With rest of the colonic mucosa being normal

3)Normal CT/MRI of Abdomen.

Exclusion Criteria

1)Known case of IBD(Ulcerative colitis, Crohnâ??s disease)

2)Known case of Intestinal tuberculosis.

3)Colonic or Ileocolonic disease(ulcer/stricture)

4)H/O Colorectal cancer or any previous colonic or intestinal surgery

5)H/O intake of ASPIRIN/NSAID in last 6 months.

6)H/O Radiation for any Intraabdominal or Pelvic malignancy

7)Those with small intestinal or colonic abnormalities on abdominal imaging(CT/MRI)

8)Overt gastrointestinal bleeding

9)Those who did not give consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients having persistent(symptomatic or asymptomatic)ulcers and/or progression of endoscopic lesions at the end of 12 monthsTimepoint: 12 MONTHS
Secondary Outcome Measures
NameTimeMethod
Risk factors for persistent and/or progressive endoscopic ulcers or lesionsTimepoint: 12 MONTHS
© Copyright 2025. All Rights Reserved by MedPath